Physician profile

Hema Krishna

Cardiovascular Disease · Rochester, MN

NPI 1811331374

$2,029.40

in general payments reported to CMS, 2019-2025

11 companies · none reported in 2025

Payments by year

General payments by program year, as reported to CMS.

What the payments were for

Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.

View as a table
Payment typeAmount (2023-2025)
Food and Beverage$288.37

Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.

Who reported paying

General payments only, as reported to CMS. Product names cover 2023-2025.

CompanyGeneral paymentsYearsTop products
Abbott Laboratories $1,166.39 2021-2024 Mitraclip
Cardiovascular Systems INC. $242.46 2019-2020
Janssen Pharmaceuticals, INC $124.93 2019
Bracco Diagnostics INC. $123.82 2022
Novartis Pharmaceuticals Corporation $105.54 2020-2024
Medtronic Vascular, INC. $102.36 2020
Boston Scientific Corporation $80.00 2023 Watchman Flx
E.R. Squibb & Sons, L.L.C. $31.10 2019
Amgen INC. $20.15 2019
Astrazeneca Pharmaceuticals LP $16.38 2019
Pfizer INC. $16.27 2019

Drugs and devices associated with these payments

CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.

If you want to bring it up

Most clinicians are glad to talk about this. A respectful way in:

These are normal questions. A good clinician will welcome them.

Share this page

Payment summary

Hema Krishna

$2,029.40

in general payments reported 2019-2025

Years
2019-2024
Top company
Abbott Laboratories

https://glasscript.com/doctor/4217321/hema-krishna

Source: CMS Open Payments, program years 2019-2025. Payments are legal and often routine.

Keep an eye on this page

Get an email when the next June refresh changes this page. No account needed.

Watch this doctor

Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.